Vestmark Advisory Solutions’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.59M Buy
51,948
+5,912
+13% +$408K 0.05% 273
2025
Q1
$3.2M Buy
46,036
+19,413
+73% +$1.35M 0.08% 268
2024
Q4
$2.29M Buy
26,623
+614
+2% +$52.8K 0.08% 239
2024
Q3
$3.1M Sell
26,009
-598
-2% -$71.2K 0.12% 191
2024
Q2
$3.8M Sell
26,607
-587
-2% -$83.8K 0.16% 144
2024
Q1
$3.49M Sell
27,194
-435
-2% -$55.9K 0.15% 162
2023
Q4
$2.86M Sell
27,629
-1,788
-6% -$185K 0.15% 178
2023
Q3
$2.68M Sell
29,417
-38,973
-57% -$3.54M 0.19% 131
2023
Q2
$5.53M Buy
68,390
+1,988
+3% +$161K 0.21% 124
2023
Q1
$5.28M Sell
66,402
-4,998
-7% -$398K 0.23% 118
2022
Q4
$4.83M Sell
71,400
-244
-0.3% -$16.5K 0.24% 110
2022
Q3
$3.57M Sell
71,644
-5,532
-7% -$276K 0.2% 133
2022
Q2
$4.3M Buy
77,176
+21,400
+38% +$1.19M 0.25% 97
2022
Q1
$3.1M Sell
55,776
-4,936
-8% -$274K 0.18% 142
2021
Q4
$3.4M Buy
60,712
+68
+0.1% +$3.81K 0.19% 118
2021
Q3
$2.91M Buy
60,644
+14,006
+30% +$672K 0.2% 125
2021
Q2
$1.95M Buy
46,638
+9,938
+27% +$416K 0.14% 193
2021
Q1
$1.24M Sell
36,700
-1,650
-4% -$55.6K 0.11% 248
2020
Q4
$1.34M Buy
38,350
+652
+2% +$22.8K 0.15% 189
2020
Q3
$1.31M Buy
37,698
+2,670
+8% +$92.7K 0.18% 166
2020
Q2
$1.15M Sell
35,028
-776
-2% -$25.4K 0.18% 161
2020
Q1
$1.08M Buy
35,804
+1,912
+6% +$57.6K 0.21% 153
2019
Q4
$981K Buy
33,892
+8,646
+34% +$250K 0.2% 152
2019
Q3
$653K Buy
25,246
+4,384
+21% +$113K 0.11% 248
2019
Q2
$532K Buy
20,862
+1,570
+8% +$40K 0.09% 267
2019
Q1
$505K Buy
+19,292
New +$505K 0.09% 278